top of page

HELP 4 HD INTERNATIONAL

Stand Up Speak Up 4 HD 🎉 Click Here

Search

During HD Awareness Month, Teva Announces News About Single Tablet, Once a Day Austedo XR!

katrina4384

Jun 12, 2024

0 min read

Recent Posts

Skyhawk Therapeutics Announces Final Fifteen-Month Results from Phase 1/2 Clinical Trial of SKY-0515 in Huntington’s Disease Patients

Skyhawk Therapeutics Announces Final Fifteen-Month Results from Phase 1/2 Clinical Trial of SKY-0515 in Huntington’s Disease Patients

Prilenia Appoints Frederick (Rick) Munschauer, MD, FAAN, as Chief Medical Officer

Prilenia Appoints Frederick (Rick) Munschauer, MD, FAAN, as Chief Medical Officer

uniQure Announces Submission of Biologics License Application for Ifezuntirgene Inilparvovec (AMT-130) in Huntington’s Disease

uniQure Announces Submission of Biologics License Application for Ifezuntirgene Inilparvovec (AMT-130) in Huntington’s Disease

Comments

bottom of page